Affinity Asset Advisors’s Medicus Sciences Acquisition Corp. Warrant MSACW Stock Holding History

Affinity Asset Advisors’s Portfolio MSACW Stock Details MSACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-33,333	Closed	-$2.93K	–	88
2022 Q4	$2.93K	Hold	33,333	–	–	﹤0.01%	62
2022 Q3	$3K	Hold	33,333	–	–	﹤0.01%	64
2022 Q2	$8K	Hold	33,333	–	–	﹤0.01%	53
2022 Q1	$14K	Hold	33,333	–	–	﹤0.01%	59
2021 Q4	$24K	Hold	33,333	–	–	0.01%	55
2021 Q3	$24K	Hold	33,333	–	–	0.01%	73
2021 Q2	$34K	Buy	+33,333	New	+$26.4K	0.01%	69

Affinity Asset Advisors's MSACW Position: Q1 2023 in Review

Affinity Asset Advisors sold out of Medicus Sciences Acquisition Corp. Warrant (MSACW) in Q1 2023, closing a stake of 33,333 shares — an estimated $2.93K sold.

Affinity Asset Advisors first reported a position in MSACW in Q2 2021 and held it in 7 quarters. The position peaked at $34K in Q2 2021. 0 funds tracked by Wall St. Rank hold MSACW as of Q1 2023.

Affinity Asset Advisors reported no remaining Medicus Sciences Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Affinity Asset Advisors sold 33,333 Medicus Sciences Acquisition Corp. Warrant shares in Q1 2023, an estimated $2.93K.
Affinity Asset Advisors first reported a position in Medicus Sciences Acquisition Corp. Warrant in Q2 2021 and held it in 7 quarters.
Affinity Asset Advisors's Medicus Sciences Acquisition Corp. Warrant position peaked at $34K in Q2 2021.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Warrant as of Q1 2023.

Based on Affinity Asset Advisors's 13F filing for Q1 2023, filed 15 May 2023.